The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets

When:  Oct 21, 2021 from 15:30 to 17:30 (ET)

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format. "The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets" is the sixth seminar in the series.

Co-chairs
:

  • Carl H. June, MD – University of Pennsylvania
  • Ignacio Melero, MD, PhD – FIMA, Clinica Universidad de Navarra

Faculty:

  • Christian Klein, PhD – Roche Innovation Center Zurich
  • Ignacio Melero, MD, PhD – FIMA, Clinica Universidad de Navarra
  • Michael Milone, MD, PhD – University of Pennsylvania

Seminar agenda:

  • 3:30-3:35 pm ET: Welcome and Introductions
  • 3:35-4:50 pm ET: Faculty Presentations
  • 4:50-5:20 pm ET: Question and Answer Session
  • 5:20-5:30 pm ET: Closing Remarks

Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals  (as of 10/05/2021).